---
title: "ACST-2: Both CAS and CEA provide “similarly durable protection” against stroke at 10 years"
date: "2025-10-30T12:04:40.000Z"
publishedDate: "30 octobre 2025"
summary: "Sharing 10-year findings from the ACST-2 trial at the 39th European Society for Vascular Surgery (ESVS) annual meeting (23–26 September, Istanbul, Türkiye), Alison Halliday (University of Oxford, Oxford, UK) highlighted that, if successful, both carotid artery stenting (CAS) and carotid endarterectomy (CEA) “substantially reduce long-term stroke rates”. ACST-2 is an international, multicentre, randomised controlled trial [&#8230;] The post ACST-2: Both CAS and CEA provide “similarly durable protection” against stroke at 10 years appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/acst-2-both-cas-and-cea-provide-similarly-durable-protection-against-stroke-at-10-years/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-10-30-acst-2-both-cas-and-cea-provide-similarly-durable-protection-against-stroke-at-10-years"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/10/Image-17.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/acst-2-both-cas-and-cea-provide-similarly-durable-protection-against-stroke-at-10-years/"
---

![ACST-2: Both CAS and CEA provide “similarly durable protection” against stroke at 10 years](https://vascularnews.com/wp-content/uploads/sites/7/2025/10/Image-17.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/acst-2-both-cas-and-cea-provide-similarly-durable-protection-against-stroke-at-10-years/*

## L’essentiel

Sharing 10-year findings from the ACST-2 trial at the 39th European Society for Vascular Surgery (ESVS) annual meeting (23–26 September, Istanbul, Türkiye), Alison Halliday (University of Oxford, Oxford, UK) highlighted that, if successful, both carotid artery stenting (CAS) and carotid endarterectomy (CEA) “substantially reduce long-term stroke rates”. ACST-2 is an international, multicentre, randomised controlled trial [&#8230;] The post ACST-2: Both CAS and CEA provide “similarly durable protection” against stroke at 10 years appeared first on Vascular News .

## Lien source

https://vascularnews.com/acst-2-both-cas-and-cea-provide-similarly-durable-protection-against-stroke-at-10-years/
